Metaescaline
 |
| Names |
| IUPAC name
2-(3-ethoxy-4,5-dimethoxyphenyl)ethanamine
|
| Identifiers |
|
|
90132-31-3 Y |
| ChEMBL |
ChEMBL126963 Y |
| ChemSpider |
21106344 Y |
| Jmol interactive 3D |
Image |
-
InChI=1S/C12H19NO3/c1-4-16-11-8-9(5-6-13)7-10(14-2)12(11)15-3/h7-8H,4-6,13H2,1-3H3 Y
Key: HNBAVLIQFTYMAX-UHFFFAOYSA-N Y
-
InChI=1/C12H19NO3/c1-4-16-11-8-9(5-6-13)7-10(14-2)12(11)15-3/h7-8H,4-6,13H2,1-3H3
Key: HNBAVLIQFTYMAX-UHFFFAOYAZ
|
|
|
| Properties |
|
|
C12H19NO3 |
| Molar mass |
225.284 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Y verify (what is Y N ?) |
| Infobox references |
|
|
Metaescaline, or 3,4-dimethoxy-5-ethoxyphenethylamine, is a lesser-known psychedelic drug. It is an analog of mescaline. Metaescaline was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 200–350 mg, and the duration listed as 8–12 hours. Metaescaline produces mental insights, entactogenic, MDMA-like effects, and TOMSO-like activation. Very little data exists about the pharmacological properties, metabolism, and toxicity of metaescaline.
See also[edit]
External links[edit]
